TB Vaccine Pipeline

TB Vaccines Pipeline

Viral Vector
Protein/Adjuvant
Mycobacterial – Killed Whole Cell or Extract
Mycobacterial – Live Attenuated

Revised 7 October 2019

Phase 1

AEC/BC02

Anhui Zhifei Longcom

Ad5Ag85A

McMaster, CanSino

ChAdOx1 85A/MVA85A (ID/IM/Aerosol)

Univ of Oxford

Phase 2a

RUTI

Archivel Farma, S.L

MTBVAC

Biofabri, TBVI, Zaragosa

ID93 + GLA-SE

IDRI, Wellcome Trust, Quratis

TB/FLU-04L

RIBSP

Phase 2b

DAR-901

Dartmouth, GHIT

M72/AS01E

GSK

H56:IC31

SSI, IAVI, EDCTP, Valneva

BCG Revaccination

Gates Medical Research Institute (GMRI)

Phase 3

Vaccae^™

Anhui Zhifei Longcom

VPM1002

SII, Max Planck, VPM, TBVI
(Phase 2/3)

Immuvac

ICMR, Cadila Pharmaceuticals

WGNV is updating is process for collecting information about candidates in the TB vaccine pipeline, including expanding collection of infomration on candidates in perclinical and earlier stages of development. More infomration on submitting candidate infomration will be available shortly.

Get Involved

If you would like to learn more about the WGNV and how you can be involved, please contact us!